References
- Nutt D. Benzodiazepine dependence in the clinic: Reason for anxiety?. TIPS 1986; 457–60
- Lupolover R., Dazzi H., Ward J. Rebound phenomena: Results of a 10 years' (1970–1980) literature review. Int Pharmacopsychiatry 1982; 17: 194–237
- Owen R. T., Tyrer P. Benzodiazepine dependence. A review of the evidence. Drugs 1983; 25: 385–98
- Morgan K., Oswald J. Anxiety caused by a short life hypnotic. Br Med J 1982; 284: 942
- Rickels K., Schweizer E., Csanalosi I., Case W. G., Chung H. Long-term treatment of anxiety and risk of withdrawal. Arch Gen Psychiatry 1988; 45: 444–50
- Lucki I., Rickels K., Geller A. M. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology 1986; 88: 426–33
- Haigh J. R. M., Feely M. Tolerance to the anticonvulsant effect of benzodiazepines. TIPS 1988; 9: 361–6
- Ellinwood EH, Jr, Linnoila M., Easler M. E., Molter D. W. Profile of acute tolerance to three sedative anxiolytics. Psychopharmacology 1983; 79: 137–41
- Lucki I., Rickels K. The behavioral effects of benzodiazepines following long-term use. Psychopharmacology Bull 1986; 22: 424–33
- Greenblatt D. J., Shader R. I. Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations. Drug Metab Rev 1978; 8: 13–28
- Petersen E. N., Jensen L. H. Chronic treatment with lorazepam and FG 7142 may change the effects of benzodiazepine receptor agonists antagonists and inverse agonists by different mechanisms. Eur J Pharmacol 1987; 133: 309–17
- Stephens D. N., Schneider H. H. Tolerance to the benzodiazepine diazepam in an animal model of anxiolytic activity. Psychopharmacology 1985; 87: 322–7
- Ryan G. P., Boisse N. R. Experimental induction of benzodiazepine tolerance and physical dependence. J Pharm Exp Ther 1983; 226: 100–7
- Henauer S. A., Gallaher E. J., Hollister L. E. Long-lasting single-dose tolerance to neurologic deficits induced by diazepam. Psychopharmacology 1984; 82: 161–3
- Lukas S. E., Griffiths R. R. Precipitated diazepam withdrawal in baboons: Effect of dose and duration of diazepam exposure. Eur J Pharmacol 1984; 100: 163–71
- Cumin R., Bonetti E. P., Scherschlicht R., Haefely W. E. Use of the specific benzodiazepine antagonist. Ro 15–1788 in studies of physiological dependence on benzodiazepines. Experientia 1982; 38: 833–4
- Braestrup C., Honoré T, Nielsen M., Petersen E. N., Jensen L. H. Ligands for benzodiazepine receptors with positive and negative efficacy. Biochem Pharmacol 1984; 33: 859
- Costa E. Polytypic signaling at GABAergic synapses. Life Sci 1987; 42: 1407–17
- Mierlak D., Farb D. H. Modulation of neurotransmitter receptor desensitization: chlordiazepoxide stimulates fading of the GABA response. J Neurosci 1988; 8: 814–20
- Sher P. K., Study R. E., Mazzetta J., Barker J. L., Nelson P. G. Depression of benzodiazepine binding and diazepam potentiation of GABA-mediated inhibition after chronic exposure of spinal cord cultures to diazepam. Brain Res 1983; 268: 171–6
- Richards J. G., Schoch P., Haring P., Takacs B., Mohler H. Resolving GABAA/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies. J Neurosci 1987; 7: 1866–6
- Brodgen R. N., Goa K. L. Flumazenil. A preliminary review of its benzodiazepine antagonist properties intrinsic activity and therapeutic use. Drugs 1988; 35: 448–67